Mithra to Host Webcast for Half Year Financial Results on 24 September 2020

Liege, Belgium, 21 September 2020 – 18:00  CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces that it will host a live webcast on Thursday, 24 September 2020 at 15:00 CEST/ 09:00 EDT to announce its 2020 Half Year financial and operating results. The live webcast can be accessed on the Mithra website […]

Mithra’s EGM Approves Warrant Plan for Share Lending Shareholders

Liege, Belgium, 07 July 2020 – 17:45 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces that the Company’s Extraordinary General Meeting (EGM) held on 7 September 2020 approved the issuance of 300,000 warrants for the benefit of François Fornieri, Alychlo NV, and Noshaq SA (together the share lending shareholders), […]

Publication of a Transparency Notification Received from Alychlo NV

Liege, Belgium, 20 August 2020 – 17:45 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the “Transparency Law”), that […]

Mithra Announces Commercial Launch of Myring™ in the Netherlands

Liege, Belgium, 19 August 2020 – 7:30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces the commercial launch of its vaginal contraceptive ring Myring™ in the Netherlands.

Notice of Extraordinary Shareholders’ Meeting on 7th September 2020 Regarding Proposed Warrant Plans

Liège, Belgium, 7 August 2020 – 7:30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces the publication of the invitation to its Extraordinary General Shareholders’ Meeting (EGM) that will be held on Monday September 7 2020 at 2:00 PM (CET) in Flémalle 57 rue de l’Expansion (Belgium).  

Information on the Total Number of Voting Rights (Denominator) Following the Completion of the LDA Capital Increase

Liege, Belgium, 05 August 2020 – 17:45 CEST –In accordance with article 15 of the Belgian Act of 2 May 2007 on the disclosure of major participations in issuers of which shares are admitted to trading on a regulated market and regarding miscellaneous provisions, Mithra Pharmaceuticals SA (the “Company” or “Mithra”) announces the below information, following the […]

Mithra Announces Shelf Life Extension for Myring™ to 36 Months

Shelf life extended from 24 to 36 months in Europe Competitive advantage in terms of optimizing the supply chain costs and convenience for distributors, pharmacists and patients Liege, Belgium, 4 August 2020 – 7:30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces that the European Authorities have approved the […]

Mithra Announces Commercial Launch of Tibelia® in Canada

First tibolone-based hormone treatment available in Canada, offering a new treatment option for menopausal women Mithra’s product commercialized by BioSyent Pharma for a growing annual market value of EUR 132 million Canadian launch generates additional revenues for Mithra through sales related milestones Liege, Belgium, 30 July 2020 – 7:30 CEST – Mithra (Euronext Brussels: MITRA), […]

Mithra’s EGM Approves Warrant Plan for LDA Capital

Liege, Belgium, 23 July 2020 – 7:30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces that the Company’s Extraordinary General Meeting (EGM) held on 22 July 2020 approved the issuance of 690,000 warrants for the benefit of LDA Capital Ltd. The warrants were issued as part of the transaction announced on April 24 2020.

Mithra Signs License and Supply Agreement for Commercialization of Myring™ in Mexico

Mithra grants exclusive license to Megalabs for commercialization of its vaginal contraceptive ring in Mexico Strengthening of the commercial presence in Latin and South America thanks to this second contract with Megalabs Myring™ licenses granted to industry leaders in 35 countries, including the world’s three largest markets Liege, Belgium, 14 July 2020 – 7:30 CEST […]